Koga, Hironori <br/><br/>
Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  May 2003 
 - 1086-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1053/jhep.2003.50186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>CDC2-CDC28 Kinases<br/>Carcinoma, Hepatocellular<br/>Cell Cycle Proteins--genetics<br/>Chromans--pharmacology<br/>Cyclin E--genetics<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Cyclin-Dependent Kinases--metabolism<br/>Cyclins--genetics<br/>Down-Regulation<br/>Drug Resistance, Neoplasm<br/>G1 Phase--physiology<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Liver Neoplasms<br/>Protein Binding<br/>Protein Serine-Threonine Kinases--metabolism<br/>RNA, Messenger--analysis<br/>S-Phase Kinase-Associated Proteins<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Troglitazone<br/>Tumor Cells, Cultured<br/>Tumor Suppressor Proteins--genetics